New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID‐19) vaccination have been reported. Herein, we report a case of a man who developed anti‐glutamic acid decarboxylase (GAD) antibody‐positive fulminant type 1 diabetes 15 weeks after COVID‐19 vaccination, atypic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Takaaki, Yakou, Fumiyoshi, Saburi, Masuo, Hirose, Ai, Akaoka, Hiroaki, Hirota, Yusuke, Yunaiyama, Daisuke, Asahi, Nobuteru, Ohno, Atsushi, Matsushita, Takaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576963/
https://www.ncbi.nlm.nih.gov/pubmed/36267825
http://dx.doi.org/10.1002/ccr3.6473
Descripción
Sumario:Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID‐19) vaccination have been reported. Herein, we report a case of a man who developed anti‐glutamic acid decarboxylase (GAD) antibody‐positive fulminant type 1 diabetes 15 weeks after COVID‐19 vaccination, atypical of the previously reported anti‐GAD antibody‐negative cases.

Ejemplares similares